| __timestamp | Alnylam Pharmaceuticals, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 15879000000 |
| Thursday, January 1, 2015 | 41097000 | 16560000000 |
| Friday, January 1, 2016 | 47159000 | 19427000000 |
| Sunday, January 1, 2017 | 89912000 | 20776000000 |
| Monday, January 1, 2018 | 74908000 | 22561000000 |
| Tuesday, January 1, 2019 | 219750000 | 26145000000 |
| Wednesday, January 1, 2020 | 492853000 | 42518000000 |
| Friday, January 1, 2021 | 844287000 | 46385000000 |
| Saturday, January 1, 2022 | 1037418000 | 46159000000 |
| Sunday, January 1, 2023 | 1828292000 | 45006000000 |
| Monday, January 1, 2024 | 2248243000 | 48300000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceuticals, revenue growth is a key indicator of a company's market position and innovation prowess. Over the past decade, Bristol-Myers Squibb Company (BMY) and Alnylam Pharmaceuticals, Inc. (ALNY) have showcased contrasting trajectories in their annual revenues.
From 2014 to 2023, Bristol-Myers Squibb has consistently demonstrated its dominance, with revenues peaking at approximately $46 billion in 2021, marking a robust 190% increase from 2014. In contrast, Alnylam Pharmaceuticals, a pioneer in RNA interference therapeutics, has shown remarkable growth, albeit on a smaller scale. Starting with a modest revenue of around $50 million in 2014, Alnylam's revenue surged to nearly $1.8 billion by 2023, reflecting an impressive 3,500% increase.
This revenue showdown highlights the dynamic nature of the pharmaceutical industry, where established giants and innovative newcomers both find their place in the market.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Alnylam Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited: Examining Key Revenue Metrics
Alnylam Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. vs Grifols, S.A.: Annual Revenue Growth Compared
Alnylam Pharmaceuticals, Inc. or ADMA Biologics, Inc.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.